Is Olema Pharmaceuticals, Inc. (OLMA) a Buy, Sell, or Hold?
Olema Pharmaceuticals, Inc.
NASDAQ:OLMA
$11.85 USD
$0 (0.0%)
- Volume
- 817.01K
- Average Volume
- 1.43M
- Market Capitalization
- $1.04B
- P/E Ratio
- -5.87
- Dividend Yield
- 0.00%
- Price Target
- $38.00
- Year High
- $36.26
- Year Low
- $4.37
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.88
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
24
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
45
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.81M
OLMA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
OLMA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| Harmon Cyrus | director | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| BUTITTA CYNTHIA M | director | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| Garland J. Scott | director | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| Hrustanovic Gorjan | director | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| CLARK IAN T | director | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| Larson Yi | director | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| Horning Sandra | director | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| Raman Prakash | director | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| RAPPAPORT ANDREW | director | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| Graham G. Walmsley | director | 2026-06-18 | A-Award | 9.51 | 2026-06-23 |
| Raman Prakash | director | 2026-04-28 | A-Award | 14.59 | 2026-04-29 |
| Raman Prakash | director | 2026-04-28 | A-Award | 14.59 | 2026-04-29 |
| Raman Prakash | 2026-04-28 | 0 | 2026-04-29 | ||
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | 2026-03-03 | M-Exempt | 4.37 | 2026-03-05 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | 2026-03-04 | M-Exempt | 4.37 | 2026-03-05 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | 2026-03-04 | M-Exempt | 4.37 | 2026-03-05 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | 2026-03-03 | M-Exempt | 4.37 | 2026-03-05 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | 2026-03-04 | S-Sale | 24.25 | 2026-03-05 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | 2026-03-03 | S-Sale | 23.01 | 2026-03-05 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | 2026-03-04 | S-Sale | 24.69 | 2026-03-05 |
| Austin Sasha Lu | officer: VP of Finance and Controller | 2026-02-02 | A-Award | 25.65 | 2026-02-17 |
| Austin Sasha Lu | officer: VP of Finance and Controller | 2026-02-02 | A-Award | 0 | 2026-02-17 |
| Austin Sasha Lu | officer: VP of Finance and Controller | 2026-01-30 | 0 | 2026-02-17 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | 2026-01-30 | 4.87 | 2026-02-17 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | 2026-02-01 | 2.44 | 2026-02-17 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | 2026-01-30 | 3.49 | 2026-02-17 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | 2026-01-30 | 15.25 | 2026-02-17 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | 2026-01-30 | 4.37 | 2026-02-17 | |
| Zojwalla Naseem | officer: CHIEF MEDICAL OFFICER | 2026-02-02 | A-Award | 25.65 | 2026-02-04 |
| Zojwalla Naseem | officer: CHIEF MEDICAL OFFICER | 2026-02-02 | A-Award | 25.65 | 2026-02-04 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2026-02-02 | A-Award | 25.65 | 2026-02-04 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2026-02-02 | A-Award | 25.65 | 2026-02-04 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | 2026-02-02 | A-Award | 25.65 | 2026-02-04 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | 2026-02-02 | A-Award | 25.65 | 2026-02-04 |
| Bohen Sean | director, officer: PRESIDENT AND CEO | 2026-02-02 | A-Award | 25.65 | 2026-02-04 |
| Bohen Sean | director, officer: PRESIDENT AND CEO | 2026-02-02 | A-Award | 25.65 | 2026-02-04 |
| Harmon Cyrus | director | 2026-01-20 | S-Sale | 26.88 | 2026-01-21 |
| Harmon Cyrus | director | 2026-01-14 | S-Sale | 29.12 | 2026-01-16 |
| Kovacs Shane William Charles | officer: CH. OPERATING & FINANCIAL OFF. | 2026-01-13 | S-Sale | 28.01 | 2026-01-15 |
| Kovacs Shane William Charles | officer: CH. OPERATING & FINANCIAL OFF. | 2026-01-15 | S-Sale | 28.73 | 2026-01-15 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2026-01-14 | M-Exempt | 4.87 | 2026-01-14 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2026-01-14 | S-Sale | 28.6 | 2026-01-14 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2026-01-13 | S-Sale | 27.6 | 2026-01-14 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2026-01-14 | S-Sale | 28.99 | 2026-01-14 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2026-01-13 | S-Sale | 28.49 | 2026-01-14 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2026-01-12 | S-Sale | 28.34 | 2026-01-14 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2026-01-13 | M-Exempt | 4.87 | 2026-01-14 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2026-01-14 | M-Exempt | 4.87 | 2026-01-14 |
| Bohen Sean | director, officer: President and CEO | 2025-12-26 | G-Gift | 0 | 2025-12-30 |
| Harmon Cyrus | director | 2025-12-22 | S-Sale | 28.53 | 2025-12-29 |
| CLARK IAN T | director | 2025-12-19 | M-Exempt | 4.08 | 2025-12-23 |
| CLARK IAN T | director | 2025-12-19 | M-Exempt | 7.84 | 2025-12-23 |
| CLARK IAN T | director | 2025-12-19 | S-Sale | 28.83 | 2025-12-23 |
| CLARK IAN T | director | 2025-12-19 | M-Exempt | 3.61 | 2025-12-23 |
| CLARK IAN T | director | 2025-12-19 | M-Exempt | 4.406 | 2025-12-23 |
| CLARK IAN T | director | 2025-12-19 | S-Sale | 29.71 | 2025-12-23 |
| CLARK IAN T | director | 2025-12-19 | M-Exempt | 4.08 | 2025-12-23 |
| CLARK IAN T | director | 2025-12-19 | M-Exempt | 7.84 | 2025-12-23 |
| CLARK IAN T | director | 2025-12-19 | M-Exempt | 3.61 | 2025-12-23 |
| CLARK IAN T | director | 2025-12-19 | M-Exempt | 4.406 | 2025-12-23 |
| CLARK IAN T | director | 2025-12-19 | S-Sale | 30.48 | 2025-12-23 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2025-12-19 | S-Sale | 28.08 | 2025-12-23 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2025-12-19 | S-Sale | 30.4 | 2025-12-23 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2025-12-19 | S-Sale | 31.39 | 2025-12-23 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2025-12-19 | G-Gift | 0 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-22 | M-Exempt | 7.02 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-19 | M-Exempt | 15.25 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-23 | M-Exempt | 7.02 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-19 | M-Exempt | 15.25 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-22 | M-Exempt | 7.02 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-22 | M-Exempt | 15.25 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-19 | S-Sale | 28.03 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-22 | M-Exempt | 15.25 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-19 | S-Sale | 28.93 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-23 | M-Exempt | 7.02 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-22 | S-Sale | 28.04 | 2025-12-23 |
| Zojwalla Naseem | officer: Chief Medical Officer | 2025-12-23 | S-Sale | 27.66 | 2025-12-23 |
| Kovacs Shane William Charles | officer: CH. OPERATING & FINANCIAL OFF. | 2025-12-08 | G-Gift | 0 | 2025-12-09 |
| Kovacs Shane William Charles | officer: CH. OPERATING & FINANCIAL OFF. | 2025-11-26 | G-Gift | 0 | 2025-12-01 |
| RAPPAPORT ANDREW | director | 2025-11-21 | M-Exempt | 0.39 | 2025-11-25 |
| RAPPAPORT ANDREW | director | 2025-11-25 | G-Gift | 0 | 2025-11-25 |
| RAPPAPORT ANDREW | director | 2025-11-21 | M-Exempt | 0.39 | 2025-11-25 |
| Harmon Cyrus | director | 2025-09-16 | S-Sale | 8.04 | 2025-09-18 |
| Harmon Cyrus | director | 2025-09-18 | S-Sale | 8.33 | 2025-09-18 |
| Harmon Cyrus | director | 2025-09-16 | S-Sale | 8.08 | 2025-09-18 |
| Harmon Cyrus | director | 2025-09-18 | S-Sale | 8.32 | 2025-09-18 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | 2025-06-11 | A-Award | 4.08 | 2025-06-13 |
| Larson Yi | director | 2025-06-11 | A-Award | 4.08 | 2025-06-13 |
| Garland J. Scott | director | 2025-06-11 | A-Award | 4.08 | 2025-06-13 |
| Horning Sandra | director | 2025-06-11 | A-Award | 4.08 | 2025-06-13 |
| CLARK IAN T | director | 2025-06-11 | A-Award | 4.08 | 2025-06-13 |
| Hrustanovic Gorjan | director | 2025-06-11 | A-Award | 4.08 | 2025-06-13 |
| Graham G. Walmsley | director | 2025-06-11 | A-Award | 4.08 | 2025-06-13 |
| Harmon Cyrus | director | 2025-06-11 | A-Award | 4.08 | 2025-06-13 |
| BUTITTA CYNTHIA M | director | 2025-06-11 | A-Award | 4.08 | 2025-06-13 |
| RAPPAPORT ANDREW | director | 2025-06-11 | A-Award | 4.08 | 2025-06-13 |
| Graham G. Walmsley | director: | 2024-12-13 | 0 | 2025-05-13 | |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | 2025-02-28 | A-Award | 4.37 | 2025-03-03 |
| Zojwalla Naseem | officer: CHIEF MEDICAL OFFICER | 2025-02-28 | A-Award | 4.37 | 2025-03-03 |